This unit focuses on several major classes of biologically and clinically important therapeutic agents. Students will study the traditional use, isolation, structural characterisation, synthesis and clinical evaluation of drugs and also be exposed to newer crystallographic, computational, combinatorial and screening methodology used in drug design and development. The subject will consist of three inter-related sections: drug discovery and development, molecular recognition and combinatorial chemistry and the synthesis of biological polymers. Where appropriate, guest speakers from industry and government agencies will contribute to the subject. -- Course Website
Instructor: Associate Professor Lisa Martin (Clayton); Associate Professor Jenny Mosse (Gippsland)
Prerequisites: CHM2911 or CHM2762. Students who have not completed and passed one of these units should consult the third year coordinator.
